ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Predictive Oncology Inc

Predictive Oncology Inc (POAI)

0,92
0,10
(12,20%)
Geschlossen 03 Januar 10:00PM
0,874
-0,046
(-5,00%)
Nach Börsenschluss: 1:58AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,874
Gebot
0,88
Fragen
0,92
Volumen
122.735
0,8367 Tagesbereich 0,939899
0,55 52-Wochen-Bereich 3,76
Marktkapitalisierung
Handelsende
0,82
Handelsbeginn
0,8367
Letzte Trade
72
@
0.88
Letzter Handelszeitpunkt
Finanzvolumen
US$ 111.760
VWAP
0,910583
Durchschnittliches Volumen (3 Mio.)
114.255
Ausgegebene Aktien
6.666.993
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,44
Gewinn pro Aktie (EPS)
-2,1
Erlöse
1,78M
Nettogewinn
-13,98M

Über Predictive Oncology Inc

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is i... Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response. Mehr anzeigen

Sektor
Ortho,prosth,surg Appl,suply
Branche
Ortho,prosth,surg Appl,suply
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Predictive Oncology Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker POAI. The last closing price for Predictive Oncology was US$0,82. Over the last year, Predictive Oncology shares have traded in a share price range of US$ 0,55 to US$ 3,76.

Predictive Oncology currently has 6.666.993 shares in issue. The market capitalisation of Predictive Oncology is US$5,47 million. Predictive Oncology has a price to earnings ratio (PE ratio) of -0.44.

POAI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.1317.47311827960.7440.990.7379013221470.90359906CS
40.09712.48391248390.7770.990.661353050.84293806CS
120.2233.63914373090.6540.990.551142550.76990684CS
26-0.156-15.1456310681.032.990.5513439431.76618166CS
52-2.376-73.10769230773.253.760.5511303141.87107897CS
156-18.326-95.447916666719.2220.557164275.06938537CS
260-51.526-98.332061068752.41060.55115181018.41398492CS

POAI - Frequently Asked Questions (FAQ)

What is the current Predictive Oncology share price?
The current share price of Predictive Oncology is US$ 0,874
How many Predictive Oncology shares are in issue?
Predictive Oncology has 6.666.993 shares in issue
What is the market cap of Predictive Oncology?
The market capitalisation of Predictive Oncology is USD 5,47M
What is the 1 year trading range for Predictive Oncology share price?
Predictive Oncology has traded in the range of US$ 0,55 to US$ 3,76 during the past year
What is the PE ratio of Predictive Oncology?
The price to earnings ratio of Predictive Oncology is -0,44
What is the cash to sales ratio of Predictive Oncology?
The cash to sales ratio of Predictive Oncology is 3,45
What is the reporting currency for Predictive Oncology?
Predictive Oncology reports financial results in USD
What is the latest annual turnover for Predictive Oncology?
The latest annual turnover of Predictive Oncology is USD 1,78M
What is the latest annual profit for Predictive Oncology?
The latest annual profit of Predictive Oncology is USD -13,98M
What is the registered address of Predictive Oncology?
The registered address for Predictive Oncology is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Predictive Oncology website address?
The website address for Predictive Oncology is predictive-oncology.com
Which industry sector does Predictive Oncology operate in?
Predictive Oncology operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ONCBeiGene Ltd
 184,21
(731,65%)
132,21k
RAINRain Enhancement Technologies Holdco Inc
 6,75
(457,85%)
211,35k
NITON2OFF Inc
US$ 1,07
(331,45%)
603,87M
CTCXCarmell Corporation
US$ 0,6991
(150,48%)
314,15M
TXMDTherapeuticsMD Inc
US$ 1,58
(83,72%)
7,41M
NMRANeumora Therapeutics Inc
US$ 1,965
(-81,46%)
44,88M
THCHTH International Limited
US$ 0,71
(-80,00%)
50,98k
MARXMars Acquisition Corporation
US$ 2,47
(-73,58%)
1,19M
SISIShineco Inc
US$ 2,07
(-54,30%)
1,8M
MARXUMars Acquisition Corporation
US$ 6,23
(-40,10%)
66,2k
NITON2OFF Inc
US$ 1,07
(331,45%)
603,87M
CTCXCarmell Corporation
US$ 0,6991
(150,48%)
314,15M
MBIOMustang Bio Inc
US$ 0,2093
(18,25%)
310,9M
CGBSCrown LNG Holdings Ltd
US$ 0,6749
(68,68%)
279,72M
SVMHSRIVARU Holding Ltd
US$ 0,0599
(42,28%)
278,85M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht